Our Key Actions and Initiatives in the Fight against Covid Pandemics Health Sector Contributions

- More than 2500 hospitals beds and sanitary Contributions facilities mobilized - Medicalized trains to transport patients to fight - A dozen sites used as testing centers Covid-19 crisis - Research on medications and vaccines - Contribution to provide critical equipment: 7 million masks, 230,000 desinfectant gels, 500,000 pairs of gloves, 50 ventilators.

Donations (charitable initiatives and government funding to support the economy)

- Over € 500 000 in donations - Food charity support to serve thousands of meals Contributions to fight Covid-19 crisis in all our geographies AFRICA

EUROPE

AMERICA

3 Contributions to the Health Sector to fight Covid-19 crisis

➢ More than 2500 hospitals beds and sanitary facilities mobilized

➢ Medicalized trains to transport patients

➢ A dozen sites used as testing centers

➢ Research on medications and vaccines

➢ Contribution to provide critical equipment: 7 million masks, 230,000 desinfectant gels, 500,000 pairs of gloves, 50 ventilators

4 Health sector contributions (1/2) More than 2500 beds mobilized and dedicated to crisis • Turkey ✓ Adana Hospital: More than 350 beds dedicated to COVID-19 patients while the Rehabilitation Hospital serves as accommodation block for medical staff. ✓ Yozgat Hospital: 475 beds allocated to pandemic patients only. 17 rooms converted to ‘negative pressure’ rooms, 17 isolated rooms of infection service, 34 Intensive care units for adults, 27 intensive care units for children & 12 post-op rooms also serves for pandemic patients. ✓ Elazig Integrated Healthcare Campus: 329 rooms dedicated to COVID-19 patients and 154 intensive care units. Production of masks and hand sanitizer in the hospital’s premises for the additional needs. ✓ Bursa Integrated Healthcare Campus: 560 beds reserved to COVID-19 patients and 200 extra beds in the PTR building. Virological (PCR) testing for fast screening of COVID19 patients in the Hospital.

• Chile (Felix Bulnes Hospital, Santiago): ✓ The opening of the hospital on April 18 contributed to the government’s plan to add beds to the healthcare system to tackle the pandemic. ✓ The 523 beds account for 30% of the plan and turned into 100% COVID- 19 treatment to respond to the Governements’ request

• UK (Fulcrum) ✓ Several facilities mobilized by the NHS to support Emergency Departments of nearby hospitals. ✓ A dozen sites identified/used as COVID-19 testing centers. ✓ LIFT actively working with the NHS throughout this crisis and sharing best 5 practices to help make decisions quickly. Health sector contributions (2/2) Critical equipment, medicalized trains, research

• Gabon and Mauritania - contribution with partner Arise to provide critical equipment ✓ 7 millions of masks, 143,000 pieces of protective clothing, 25 thermographic cameras, 230,000 desinfectant gels, 10,000 smart thermometers, 500,000 pairs of gloves, 50 ventilators.

• France ✓ TGV Tours Bordeaux mobilised to evacuate COVID-19 patients from Paris to Bordeaux in medicalized trains. ✓ Annemasse Bonneville Hospital fully mobilized to prepare and maintain the building to handle infected patients (Plan Blanc triggered by the Authorities), isolating specific areas of the hospital (negative pressure). New protocols implemented. ✓ Rennes Hospital has a key role for sterilization unit and pharmacy. • Canada (CRCHUM, Montreal) ✓ Rooms used for training in the research center converted to testing room, to test doctors and nurses working at the CHUM hospital next door. ✓ Under a joint initiative by the Fonds de recherche du Québec and Génome Québec, a task force combining research teams from across the province, including those of the CRCHUM, are setting up the first Quebec Biobank to advance research efforts studying COVID-19. • Spain (Gipuzkoa) ✓ Waste to Energy facility is incinerating COVID-19 contaminated medical waste. • Slovakia (R1) ✓ Local hospitals supports, mostly with disinfection hard/software and various types 6 of masks. Donations (charitable initiatives and government funding to support the economy) to fight Covid-19 crisis

➢ Over € 500 000 in donations

➢ Food charity support to serve thousands of meals

7 Over 500 000 € in Donations

• France : 100 000 € Contribution to the French government solidarity fund for SMEs.

• Senegal : 75 000 € contribution to the Emergency Funds for Senegal.

• Ethiopia (Tulu Moye Geothermal): 160 000 USD donations ✓ USD 30,000 at local community level where the project is located ✓ USD 30,000 in cash contribution to the Oromia Regional government and ✓ USD 100,000 at the Federal level.

• Jordan (Amman International Airport): ✓ 200 k USD contribution to the Jordanian Government’s National Aid Fund. ✓ Full salaries paid for all AIG employees despite Govt decree enabling reduced wages. ✓ Financial assistance to local airlines, airport tenants and servicers (to ensure maximal employment and mitigate negative social consequences).

• USA : 30 000 USD donations to local Washington DC foundations ✓ Greater Washington Community Foundation Established a COVID-19 Emergency Response Fund and an initiative to provide e-learning devices to students to support distance learning ✓ Capital Area Food Bank Serves the entire Capital Region but includes 125,000 food insecure Prince Georgian’s ✓ Mission of Love Charities Smaller food bank in Prince George’s County serving community 8 Food charity support to serve thousands of meals

• USA

✓ Central 70 supported Mobile Food Markets charity (438 families). SPV employees have also been sewing masks for the medical community. ✓ Port of Miami: Support to the Port staff through delivery of lunches to all Port personnel, which also helps a local Greek restaurant keep their employees working.

• Ireland (Limerick Tunnel):

✓ Donations to the St.Munchin’s Community Centre (Limerick) to serve over 400 meals per day to the older community

9 Disclaimer

The information contained in this presentation (this “Presentation”) is provided for informational and discussion purposes only and is not, and may not be relied on in any manner as, legal, tax or investment advice or as an offer to sell or a solicitation of an offer to buy an interest in any fund or other vehicle to be managed or advised (or to be managed or advised) by Meridiam SAS, Meridiam Infrastructure North America Corporation or any of its affiliates (“Meridiam”) (a “Meridiam Fund”). A private offering of interests in any Meridiam Fund (“Interests”) will only be made pursuant to a confidential private placement memorandum (a “Memorandum”) and the limited partnership agreement and subscription documents relating to such Meridiam Fund, which will be furnished to qualified investors on a confidential basis at their request for their consideration in connection with any such offering. The information contained in this presentation will be qualified in its entirety by reference to any relevant Memorandum, which will contain additional information about the investment objective, terms and conditions of an investment in any relevant Meridiam Fund and will also contain tax information and risk disclosures that will be important to any investment decision regarding any Meridiam Fund. An investment in the any Meridiam Fund will involve significant risks, including loss of the entire investment. Private funds are speculative investments and are not suitable for all investors, nor do they represent a complete investment program. Any Meridiam Fund will be available only to qualified investors who are comfortable with the substantial risks associated with investing in private funds. Interests are illiquid, as there is no guarantee there will be a secondary market for Interests. There will also be restrictions on transferring Interests. Investments in any Meridiam Fund may be leveraged and investment performance may be volatile. The fees and expenses charged in connection with any Meridiam Fund may be higher than other investment alternatives and will offset profits, if any. Before deciding to invest in any Meridiam Fund, prospective investors in any Meridiam Fund should read the relevant Memorandum and pay particular attention to the risk factors contained in such Memorandum. In considering any performance data contained herein, recipients should bear in mind that past, projected or targeted performance is not indicative of future results, and there can be no assurance that any Meridiam Fund will achieve comparable results or that projected or target returns will be met. Recipients should also bear in mind that past, projected or targeted portfolio characteristics are not indicative of future portfolio characteristics and there can be no assurance that any Meridiam Fund will have comparable portfolio characteristics or that target portfolio characteristics will be achieved. Gross IRRs do not reflect any management fees, carried interest and other fund expenses (including development costs) borne by investors, which in the aggregate may be substantial. Net IRRs are after management fees, carried interest and allocable expenses. Fund investor withholding taxes are not reflected in the Net IRRs. All projected IRRs presented are annualized and calculated on the basis of quarterly investment inflows and outflows. Nothing contained herein should be deemed to be a prediction or projection of future performance of any Meridiam Fund. Recipients should refer to the more detailed descriptions and disclaimers relating to projected IRRs contained in any relevant Memorandum relating to any Meridiam Fund. Recipients should make their own investigations and evaluations of the information contained herein. Each recipient should consult its own attorney, business adviser and tax adviser as to legal, business, tax and related matters concerning the information contained herein and the Interests. Except where otherwise indicated herein, the information contained herein, including statements concerning financial market trends, is based on matters as they exist as of the date of preparation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available, or circumstances existing or changes occurring after the date hereof. Certain information contained herein constitutes “forward-looking statements,” which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “target,” “project,” “estimate,” “intend,” “continue” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or the actual performance of any Meridiam Fund may differ materially from those reflected or contemplated in such forward-looking statements. Recipients should not rely on these forward-looking statements in deciding whether to invest in any Meridiam Fund. Certain information contained herein has been obtained from third party sources, while such information is believed to be reliable for the purposes used herein, neither Meridiam nor any of its affiliates or partners, members or employees, assume any responsibility for the accuracy of such information. No Interests have not been approved or disapproved by the U.S. Securities and exchange commission (the “SEC”) or by the securities regulatory authority of any state or of any other jurisdiction. No Interests have been registered under the U.S. Securities act of 1933, as amended, the securities laws of any other state or the securities laws of any other jurisdiction, nor is such registration contemplated. No Meridiam Fund will be registered as an investment company under the investment company act of 1940, as amended (the “Investment Company Act”). Consequently, limited partners of any Meridiam Fund will not be afforded the protections of the Investment Company Act. The information contained herein must be kept strictly confidential and may not be reproduced or redistributed to any person in any format without the approval of Meridiam. Each recipient acknowledges that (i) certain information contained herein may constitute material non-public information in respect of certain investments held by Meridiam Funds and may not be used to trade in securities on the basis of any such information and (ii) this Presentation may be used for the sole purpose of evaluating a possible investment in a new Meridiam Fund. By accepting this Presentation, each recipient agrees to the foregoing.

10